A Review Drug and Biochemical Pharmacology Discovery
Abstract
Keywords
Full Text:
PDFReferences
Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nature Chemical Biology. 2008; 4(11): 682–690p.
Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, Cibrián-Uhalte E, Davies M. The ChEMBL database in 2017. Nucleic Acids Research. 2017; 45(D1): D945–D954.
Drews J. Drug discovery: A historical perspective. Science. 2000; 287(5460): 1960–1964p.
Goh KI, Cusick ME, Valle D, Barabasi AL. The human disease network. Proc Natl Acad Sci USA. 2007; 104(21): 8685–8690p.
Eric ES. Molecular networks as sensors and drivers of common human diseases. Nature. 2009; 461(7261): 218–223p.
Nelson MR, Tipney H, Painter JL, Shen J, Nicoletti P, Shen Y, Floratos A, Sham PC, Li MJ, Wang J, Cardon LR, Whitaker JC. The support of human genetic evidence for approved drug indications. Nat Genet. 2015; 47(8): 856–860p.
Yanghe F, Qi W, Tengjiao W. Drug target discovery through network analysis: computational considerations. Curr Pharm Des. 2010; 16(17): 1897–1908p.
Silwoski G, Kothiwale S, Meiler J, Lowe EW. Computational methods of drug discovery. Pharmacol Rev. 2014; 66(1): 334–395p. 9. Johnson B, Loree JM, Jacome AA. Atypical, Non-V600 BRAF mutations as a potential mechanism of resistance to EGFR inhibition in metastatic colorectal cancer. JCO Precis Oncol. 2019; 3: PO.19.00102. doi: 10.1200/PO.19.00102.
Smith MP, Ferguson HR, Ferguson J, Zindy E, Kowalczyk KM, Kedward T, Bates C, Parsons J, Watson J, Chandler S. Reciprocal priming between receptor tyrosine kinase at recycling endosomes orchestrates cellular signaling outputs. The EMBO J. 2021; 40: e107182. doi: https://doi.org/10.15252/embj.2020107182.
Melone V, Salvati A, Palumbo D, Giurato G, Nassa G, Rizzo F, Palo L, Giordano A, Incoronato M, Vitale M, Mian C, Di I, Cristiano S. Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omic analysis. J Trans Med. 2022; 20: 306p.
Boobphahom S, Ly NM, Soum V, Pyun N, Kwon OS, Rodthongkum N, Shin K. Recent advances in microfluidic paper-based analytical devices toward high throughput screening. Molecules. 2020; 25(13): 2970p. doi: 10.3390/molecules25132970.
Gawriljuk VO, Zin PPK, Puhl AC, Zorn KM, Foil DH, Lane TR, Hurst B, Tavella TA, Costa FTM, Lakshmanane PK, Godoy AS. Machine learning models identify inhibitors of SARS-CoV-2. J Chem Inf Model. 2021; 61(9): 4224–4235p.
Nitesh MT, Anupam B. High throughput virtual screening (HTVS) of peptide library: technological advancement in ligand discovery. Eur J Med Chem. 2022; 243:114766. doi: 10.1016/j.ejmech.2022.114766.
Malapaka VRR, Barrase AA, Tripp BC. High throughput screening for antimicrobial compounds using a 96-well format bacterial motility absorbance assay. J Biomol Screen. 2007; 12(6): 849–854p. doi: 10.1177/1087057107304478.
Xin PH. Pterocarpans and their biological activities: A review. Chin Med J. 2021; 46(17): 4323–4333p.
Siveen KS, Sikka S, Surana R, Dai X, Zhang J, Kumar AP, Tan BKH, Sethi G, Bishayee A. Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. Biochim Biophys Acta. 2014; 1845(2): 136–154p. doi: 10.1016/j.bbcan.2013.12.005.
Roy A, Khan A, Ahmad I, Alghamdi S, Rajab BS, Babalgith AO, Alshahrani MY. Flavonoids a Bioactive Compound from Medicinal Plants and Its Therapeutic Applications. Biomed Res Int. 2022; 2022: 5445291. doi: 10.1155/2022/5445291.
Nuzzo G, Senese G, Gallo C, Albiani F, Romano L, Manzo E, Fontana A. Antitumor Potential of Immunomodulatory Natural Products. Mar Drugs. 2022; 20(6): 386p. doi: 10.3390/md20060386. 20. Liu Y, Zhang Q, Qi X, Gao H, Yu B. Metabolic engineering of Bacillus subtilis for riboflavin production: A review. Microorga. 2023; 11(1): 164pzfedcwaSS. doi: http://doi.org/10.3390/microorganisms11010164
DOI: https://doi.org/10.37591/rrjomst.v12i3.3305
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Research & Reviews: Journal of Medical Science and Technology